Skip to main content

Table 5 Fold-change in methacholine PC20 by treatment group at 8-months post-randomization among IPO13 variant carriers

From: Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma

 

Budesonide (n = 214)

Nedocromil/Placebo (n = 440)

 

SNP

Fold change (95% CI)

p-value

Fold change (95% CI)

p-value

Test for interaction

rs6671164

0.81 (0.38 – 1.68)

0.56

1.65 (1.05 – 2.61)

0.03

0.13

rs4448553

0.84 (0.40 – 1.77)

0.65

1.58 (1.00 – 2.51)

0.05

0.20

rs1990150

0.72 (0.31 – 1.69)

0.45

2.25 (1.35 – 3.74)

0.002

0.02

rs2240447

0.72 (0.34 – 1.53)

0.39

1.82 (1.14 – 2.89)

0.01

0.05

rs2486014

0.99 (0.37 – 2.62)

0.98

1.97 (1.10 – 3.53)

0.02

0.21

rs2301993

0.83 (0.39 – 1.79)

0.64

1.80 (1.13 – 2.86)

0.01

0.11

rs2301992

0.48 (0.15 – 1.52)

0.21

1.64 (0.78 – 3.47)

0.19

0.08

rs1636879

1.02 (0.38 – 2.74)

0.96

2.14 (1.20 – 3.83)

0.01

0.11

rs7412307

0.74 (0.34 – 1.60)

0.44

1.84 (1.14 – 2.96)

0.01

0.06

rs2428953

0.67 (0.26 – 1.70)

0.40

2.30 (1.32 – 4.00)

0.003

0.02

  1. Models adjusted for baseline log10-PC20, age, gender, height and clinic. Fold-change and confidence limits derived using beta-estimates derived from generalized linear models.